Court Opinion

ID: 6104226
Source: CourtListenerOpinion
Date Created: 2022-01-18 18:02:29.293571+00
Date Added: 2024-06-11T08:53:42.908430
License: Public Domain

In the United States Court of Federal Claims
                                   OFFICE OF SPECIAL MASTERS
                                       Filed: December 23, 2021

* * * * * * * * * *                            *
KATHLEEN ALMODOVA, as parent                       *       UNPUBLISHED
and natural guardian of A.A, a minor,              *
                                                   *       No. 19-1873V
                 Petitioner,                       *
                                                   *       Special Master Dorsey
v.                                                 *
                                                   *       Petitioner’s Motion for a Decision
SECRETARY OF HEALTH                                *       Dismissing Her Petition; Human
AND HUMAN SERVICES,                                *       Papillomavirus Vaccine; Tetanus-
                                                   *       Diphtheria -Acellular Pertussis (“Tdap”)
                 Respondent.                       *       Vaccine; Meningococcal Vaccine; Immune
                                                   *       Thrombocytopenic Purpura (“ITP”).
*    *   *   *     *   *       *   *   *   *   *

Amy A. Senerth, Muller Brazil, LLP, Dresher, PA, for petitioner.
Austin J. Egan, United States Department of Justice, Washington, DC, for respondent.

                                               DECISION1

        On December 11, 2019, Kathleen Almodova (“petitioner”), as parent and natural guardian
of A.A., a minor, filed a petition for compensation under the National Vaccine Injury
Compensation Program (“Vaccine Program”)2 alleging that as a result of human papillomavirus
(“HPV” or “Gardisil”), tetanus-diphtheria-acellular pertussis (“Tdap”), and Menactra
(meningococcal) vaccines on March 23, 2018, A.A. developed immune thrombocytopenic purpura
(“ITP”). Petition at Preamble. The information in the record, however, does not show
entitlement to an award under the Program.

1
  Because this Decision contains a reasoned explanation for the action in this case, the
undersigned is required to post it on the United States Court of Federal Claims’ website in
accordance with the E-Government Act of 2002. 44 U.S.C. § 3501 note (2012) (Federal
Management and Promotion of Electronic Government Services). This means the Decision will
be available to anyone with access to the Internet. In accordance with Vaccine Rule 18(b),
petitioner has 14 days to identify and move to redact medical or other information, the disclosure
of which would constitute an unwarranted invasion of privacy. If, upon review, the undersigned
agrees that the identified material fits within this definition, the undersigned will redact such
material from public access.
2
  The Program comprises Part 2 of the National Childhood Vaccine Injury Act of 1986, 42 U.S.C.
§§ 300aa-10 et seq. (hereinafter “Vaccine Act” or “the Act”). Hereafter, individual section
references will be to 42 U.S.C. § 300aa of the Act.

                                                       1
        On December 23, 2021, petitioner moved for a decision dismissing her case, stating that
“[p]etitioner is unable to retain a hematologist expert to support causation-in-fact, and will
therefore be unable to prove that she is entitled to compensation in the Vaccine Program,” and
thus, “to proceed further would be unreasonable and would waste the resources of the Court, the
respondent, and the Vaccine Program.” Petitioner’s Motion for Decision Dismissing Her
Petition, filed Dec. 23, 2021, at ¶¶ 2-3 (ECF No. 46). Petitioner states that she understands that a
decision by the Special Master will result in a judgment against her, and that she has been advised
that such judgment will end all of her rights under the Vaccine Act. Id. at ¶ 4. Petitioner states
that she intends to protect her right to file a civil action and to elect to reject the Vaccine Program
judgment to file a civil action. Id. at ¶ 6. Respondent stated via e-mail they do not object to
petitioner’s motion dismissing her petition.

        To receive compensation under the Program, petitioner must prove either (1) that she
suffered a “Table Injury”—i.e., an injury falling within the Vaccine Injury Table—corresponding
to the vaccination, or (2) that she suffered an injury that was actually caused by the vaccination.
See §§ 13(a)(1)(A) and 11(c)(1). The records submitted by petitioner show that she does not meet
the statutory requirement under § 11(c)(1)(D)(i) to establish entitlement to compensation. The
Federal Circuit has explained that the eligibility requirements in Section 11(c) are not mere
pleading requirements or matters of proof at trial, but instead are “threshold criteri[a] for seeking
entry into the compensation program.” Black v. Sec’y of Health & Hum. Servs., 93 F.3d 781,
785-87 (Fed. Cir. 1996).

        Accordingly, in light of petitioner’s motion and a review of the record, the undersigned
finds that petitioner is not entitled to compensation. Thus, this case is dismissed. The Clerk
shall enter judgment accordingly.

       IT IS SO ORDERED.

                                                       s/Nora Beth Dorsey
                                                       Nora Beth Dorsey
                                                       Special Master

                                                  2